Glucose Health, Inc.
GLUC · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -20.7% | 20.3% | -12.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -0.2% | 20.5% | 26.1% | -34.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -112% | -91.7% | -103.3% | -138.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -130.4% | -99.4% | -103.5% | -144.3% |
| EPS | -0.006 | -0.006 | -0.005 | -0.007 |
| % Growth | 6.8% | -22.9% | 31.4% | – |
| EPS Diluted | -0.006 | -0.006 | -0.005 | -0.007 |
| Weighted Avg Shares Out | 17 | 17 | 17 | 17 |
| Weighted Avg Shares Out Dil | 17 | 17 | 17 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -110.8% | -90.8% | -102.2% | -138.3% |